Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Tarsus Pharmaceuticals, Inc.

NASDAQ: TARS · Life Sciences · 3 alerts · CIK 1819790

Share price
$78.68Close, Nov 16
Market cap
$3.88B
Shares outstanding
49.31MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Tarsus Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:01 PM ET 8-K/A
M&A Deal

Tarsus Pharmaceuticals M&A Deal with Alkeus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals filed an amendment to its previous 8-K to provide required historical and pro forma financial statements following its acquisition of Alkeus Pharmaceuticals. The acquisition was originally completed on September 4, 2026, pursuant to a merger agreement dated July 31, 2026.

Counterparty
Alkeus Pharmaceuticals, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.